Alkem Laboratories Q1 Results FY27: Uniresearch Prediction and Analysis

Alkem Laboratories Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Alkem Laboratories Q1 FY27 Revenue Rs 3,748 Cr (+11.2% YoY) and PAT Rs 811 Cr (+21.5% YoY). Prepared by Kunal Singla.

Click Here – Get Free Investment Predictions

Alkem Laboratories Q1 Results FY27 – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change	Source
Alkem Laboratories Revenue (Rs Cr)	3,371	3,748	+11.2%	Uniresearch | Uniresearch trailing analysis
PAT (Rs Cr)	668	811	+21.5%	Uniresearch | Uniresearch trailing analysis
Avg Analyst Target	See screener	12-month view	–	Uniresearch trailing analysis

Alkem Laboratories Q4 FY26 Performance

Metric	Q4 FY26 Actual	vs Q1 FY26	Source
Revenue (Rs Cr)	3,603	+6.9%	Screener consolidated
PAT (Rs Cr)	251	-62.4%	Screener consolidated

Analyst Views and Growth Outlook

The Uniresearch trailing analysis projects Alkem Laboratories FY27 revenue at +11.2% and profit at +21.5% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Alkem Laboratories delivering revenue of Rs 3,603 Cr and PAT of Rs 251 Cr.

Key Watchpoints

Revenue Delivery

Key question: can Alkem Laboratories reach Rs 3,748 Cr in Q1 FY27 revenue, representing +11.2% YoY growth over the Q1 FY26 base of Rs 3,371 Cr.

PAT vs Growth Target

Profit performance of Rs 811 Cr (+21.5%) vs the Q1 FY26 base of Rs 668 Cr is the profitability watchpoint for Alkem Laboratories in Q1 FY27.

Risks

Revenue Shortfall

Revenue below the +11.2% consensus would indicate sector headwinds or execution delays for Alkem Laboratories.

Margin Pressure

Cost increases or margin compression could challenge the +21.5% PAT growth projection for Alkem Laboratories in Q1 FY27.

Conclusion

The Alkem Laboratories Q1 FY27 Uniresearch projection of Revenue Rs 3,748 Cr and PAT Rs 811 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Alkem Laboratories live on the Univest Screener.

Track Alkem Laboratories Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live FY27 alerts.

FAQs on Alkem Laboratories Q1 Results FY27

What is Uniresearch’s PAT prediction for Alkem Laboratories Q1 Results FY27?

Ans. Uniresearch projects Alkem Laboratories Q1 FY27 PAT at Rs 811 Cr (+21.5% vs Q1 FY26 base Rs 668 Cr).

What is the Revenue forecast for Alkem Laboratories Q1 Results FY27?

Ans. Alkem Laboratories Q1 FY27 Revenue is projected at Rs 3,748 Cr (+11.2% consensus).

What were Alkem Laboratories Q4 FY26 actuals for Alkem Laboratories Q1 Results FY27?

Ans. Q4 FY26 Revenue Rs 3,603 Cr and PAT Rs 251 Cr.

How many analysts cover Alkem Laboratories Q1 Results FY27?

Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.

What consensus applies to Alkem Laboratories Q1 Results FY27?

Ans. Revenue +11.2% and profit +21.5% (Uniresearch trailing analysis).

What are the main risks to Alkem Laboratories Q1 Results FY27?

Ans. Revenue missing +11.2% consensus and PAT pressure vs +21.5% growth target.

What is the Q1 FY26 base for Alkem Laboratories Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 3,371 Cr and PAT Rs 668 Cr.